Meeting
2020 Genitourinary Cancers Symposium
Association of KRT20 and KRT5 with response to neoadjuvant chemotherapy in patients diagnosed with muscle invasive bladder cancer.
Authors
Florian Roghmann
Department of Urology, Ruhr-University Bochum, Marien Hospital, Herne, Germany
Florian Roghmann , Moritz Reike , Ralph Wirtz , Maximilian Kriegmair , Philipp Erben , Karl Tully , Veronika Weyerer , Markus Eckstein , Arndt Hartmann , Felix Wezel , Christian Bolenz , Andrea Tannapfel , Joachim Noldus , Hendrik Juette
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers
Track
Urothelial Carcinoma,Adrenal Cancer,Penile Cancer,Prostate Cancer - Advanced,Prostate Cancer - Localized,Testicular Cancer,Urethral Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 38, 2020 (suppl 6; abstr 562)
Abstract #
562
Poster Bd #
L21
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Prediction of response to neoadjuvant chemotherapy of patients with muscle invasive bladder cancer by molecular subtyping and radioligand target quantitation: Preview of the Bladder BRIDGister.
First Author: Ralph M. Wirtz
Poster
2023 ASCO Genitourinary Cancers Symposium
Prediction of response to neoadjuvant chemotherapy of patients with muscle invasive bladder cancer by molecular subtyping and antibody drug conjugate target gene quantitation: Preview of Bladder BRIDGister.
First Author: Ralph M. Wirtz
Poster
2020 Genitourinary Cancers Symposium
Smoking status and PD-L1 mRNA-expression as a predictor of response to neoadjuvant chemotherapy in patients diagnosed with muscle invasive bladder cancer.
First Author: Moritz Reike
Poster
2024 ASCO Genitourinary Cancers Symposium
Characteristics, treatment patterns, and clinical outcomes of patients undergoing neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer in the real world.
First Author: Patrick Squires